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A method for the determination of circulat- 
ing immune complexes (CIC) was adapted for 
flow cytometric analysis. Human granulo- 
cytes were used to phagocytose I&-bearing 
CIC of serum from systemic lupus erythema- 
tosus (SLE) patients. A method for labeling 
the phagocytosed CIC with FITC-conjugated 
anti-human IgG was developed where the 
granulocytes remain in suspension during fix- 
ation and labeling. The fluorescence per cell, 
measured with a flow cytometer, is a measure 
of the total amount of the phagocytosed IgG. 
The results indicate that a rapid and quanti- 
tative method for the detection and measure- 
ment of phagocytosed CIC is possible using 
the flow cytometer. 
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Quantitative determination of the amount of circulat- 
ing immune complexes (CIC) in human blood can be of 
great diagnostic and prognostic value for patients with 
auto-immunological disorders, infectious diseases 
(1,3,4,9,15), and some malignant diseases (5,6,12,18). It 
appears that a reproducible and rapid method for the 
determination of CIC is useful. One of the methods cur- 
rently in use is the indirect granulocyte phagocytosis 
test (11,17,19). In this method the patient’s serum is 
added to a suspension of granulocytes isolated from a 
healthy donor. Under carefully controlled conditions, 
the CIC of the patient’s serum are phagocytosed by the 
granulocytes. After drying on a microscope slide, the 
granulocytes are fixed. IgG-bearing CIC can then be 
labeled with FITC-conjugated anti-human IgG antibod- 
ies, whereupon the phagocytosed CIC are visible as small 
fuorescent inclusions in the cells. The number of inclu- 
sions per cell is taken as a measure for the relative 
amount of CIC in the patient’s serum. This microscopic 
analysis is time-consuming, which greatly limits a more 
frequent use of this technique. Therefore we have 
adapted the granulocyte phagocytosis test so that the 
fluorescent inclusions of the granulocytes can be mea- 
sured by flow cytometry. This greatly reduces the time 
required for analysis. 
MATERIALS AND METHODS 
Preparation of Granulocytes 
Na2HP04, 0.5% [w/v] bovine serum albumin (BSA) and 
0.38% [w/v] sodium citrate, pH 7.4). The sample was 
then divided between two tubes. For venous blood 12.5 
ml of blood was diluted to 25 ml with the same buffer. 
In each tube we carefully layered 15ml Percoll (Phar- 
macia Fine Chemicals, Uppsala, Sweden) solution (den- 
sity 1.077 g/cm3, suspended in 0.2 M NaC1, 10 mM 
NaH2P04*H20, 4.4 mM Na2HP04, 27.5 mM sodium ci- 
trate and 1% [w/v] BSA) with a syringe under the cell 
suspensions. After centrifugation at 20°C for 20 min at 
1,000 x g, granulocytes and erythrocytes were pelleted 
and separated from platelets and mononuclear leuco- 
cytes by the Percoll layer. The pellet was then resus- 
pended in 35 ml of 0.155 M NH4C1 and 9.9 mM KHCO3 
to lyse the erythrocytes. After 20 min gentle shaking on 
ice the solution was centrifuged at 4°C for 5 min at 500 
x g. The pellets were diluted with 10 ml of a solution of 
0.9% (w/v) NaCl and 2.5 W/ml heparin in order to avoid 
clotting. The cells were centrifuged at 20°C for 5 min at 
500 g, and the pellet was resuspended in Hanks’ bal- 
anced salt solution (HBSS) containing 5% (w/v) BSA. 
The concentration was adjusted to lo7 celldml. The over- 
all recovery of the granulocytes was about 70%. The 
viability of the granulocytes was more than 99% as 
measured by flow cytometry using the FDA-ethidium 
bromide method. 
Phagocytosis Assay 
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donor with 0.5 ml serum of a systemic lupus erythema- 
tosus (SLE) patient. To obtain the complement necessary 
for phagocytosis, we added 0.125 ml fresh serum of the 
granulocyte donor. This mixture was incubated for 60 
min at 37°C while being shaken to promote contact 
between granulocytes and CIC. Then the cells were pel- 
leted and washed twice with 2 ml phosphate-buffered 
saline (PBS), centrifuged for 0.5 min at 700 x g, and 
resuspended in 0.1 ml PBS. While being shaken (vor- 
texed), the cells were fixed in formaldehyde by adding 
0.15 ml 10% formaldehyde buffered in PBS (PH 7.2) at 
1-min intervals during 10 min at room temperature. 
Thereafter the cells were shaken during 15 min in the 
fixative and washed twice with PBS. Phagocytosed IgG- 
bearing CIC were demonstrated as inclusions within the 
granulocytes using a direct immunofluorescence method. 
The pellet was suspended in 1 ml of a solution of FITC 
labeled goat anti-human IgG, F(ab’)2 fragment (Kalles- 
tad, Austin, TX) (1:lOO diluted with HBSS containing 
1% [w/v] BSA). The cells were then incubated for 60 rnin 
at  room temperature while being shaken, then they 
were washed with PBS and resuspended in 1 ml HBSS 
containing 5% (wh) BSA. The cell suspension was ana- 
lysed within 2 h by fluorescence microscope and flow 
cytometry. 
Fluorescence Microscopy 
For fluorescence microscopy we used a Nikon micro- 
scope (type Optiphot) equipped with an  Osram HBO 
50W Mercury lamp, a 480-500-nm excitation filter, and 
515-nm long-pass eyepiece side-absorption filter. 
Flow Cytometry 
The flow cytometer was built in our laboratory. It 
contained a flow cell with a 250 x 250-pm square flow 
channel (Precision Cells, Hicksville, NY). For the phag- 
ocytosis assay, a 3-watt argon-ion laser (model CR3, 
Coherent Radiation, Palo Alto, CA) tuned at 488nm was 
used as a light source. 
The small-angle forward light scatter was detected 
with a photodiode (model Pin 10-D, United Detector 
Technology). Fluorescence emission at 90“ was focused 
by means of a Leitz microscope object-lens (H32, NA 0.6) 
through a KV 520 and OG 530 filter combination (Scott) 
onto a Hamamatsu R 928 photomultiplier. The signals 
were analysed with a homemade multichannel analyser 
connected to a LSI 11/23 minicomputer (Digital Equip- 
ment Corporation). For each experiment at least 20,000 
cells were measured. 
RESULTS 
In the microscopic determination of phagocytosed CIC 
currently in use, the granulocytes are fixed and stained 
while they are on a microscope slide (3,18,19). Fixation 
of the granulocytes is necessary in order to allow the 
fluorescent stain to pass through the cell membrane. 
The fixation procedure used for microscopic analysis 
cannot be used for flow cytometry since cells must re- 
main in suspension. In order to fix cells in suspension, 
background fluorescence and clotting of cells must be 
avoided, whereas cell morphology must be preserved. 
Thus, we have tried several fixatives at different concen- 
trations: water-free acetone, ethanol, formaldehyde, and 
glacial acetic acid. To minimize cell clotting the fixatives 
were added slowly to the cell suspension under continu- 
ous shaking. We have obtained the best results with a 
10% solution of formaldehyde. 
The flow-cytometric indirect granulocyte phagocytosis 
assay was tested with sera from five SLE patients as 
positive samples and sera from five healthy donors as 
negative controls. The sera of the SLE patients were 
scored in the Clq-binding assay (10) by the Blood Trans- 
fusion Service of the Netherlands (Amsterdam). In this 
test, soluble high molecular immune complexes are 
measured. Microscopic examination revealed that all 
granulocytes showed faint green cytoplasmic fluores- 
cence both for positive samples and controls. Stained 
IgG-bearing immune complexes (IC) were visible as flu- 
orescent inclusions (diameter 1-2 pm). 
The results obtained from flow cytometric analysis of 
serum from an  SLE patient with a high score in the 
Clq-binding assay and those obtained with serum of a 
healthy donor are shown in Figures 1 and 2. In Figure 
1, the small-angle light scatter and fluorescence histo- 
grams of granulocytes incubated with serum of the con- 
trol and serum of the SLE patient are plotted. The figure 
clearly shows that the cells incubated with SLE serum 
have a much higher fluorescence intensity than those 
incubated with the control serum. 
In Figure 2 the same results are presented as two- 
dimensional dot plots. Both figures reveal the presence 
of a minor subpopulation of cells with a very faint 
fluorescence. 
In Table 1 the results of the flow cytometric determi- 
nation are given for five SLE patients and five healthy 
donors. Granulocytes with a fluorescence intensity above 
channel 35 (see Fig. 2) are designated as positive cells. 
When fixation was omitted, less than 1% of the cells 
were positive using patient serum and less than 0.1% 
using control serum. 
To test the day-to-day and sample-to-sample variation, 
the assay was carried out with one positive serum and 
granulocytes of a single donor on different days. The 
variation in the percentage of positive cells was less 
than 10%. The results of the granulocyte phagocytosis 
test may be dependent on the donor granulocytes. There- 
fore we have applied the test to serum of a single SLE 
patient and a single healthy donor, using granulocytes 
of four different healthy donors. The results are given in 
Table 2. 
To determine the origin of the fluorescence of the gran- 
ulocytes incubated with control serum C‘background” 
fluorescence), we have applied the following variations 
to our standard procedure: 1) When the complete proce- 
dure was followed except for the final immunofluores- 
cence staining, the fluorescence of the granulocytes was 
negligible. Thus the background fluorescence was not 
due to autofluorescence of granulocytes fixed by formal- 
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Fig. 2. Two-dimensional dot plots of the same results as in Figure 1. 
Granulocytes with a fluorescence intensity above channel 35 (f) are 
designated as positive cells. The figurea clearly show the difference 
dehyde. 2) When the procedure was followed without 
furation, the median fluorescence dropped to less than 
10%. Therefore the background fluorescence is mainly 
due to the combination of fixation and staining. 3) Omis- 
sion of the incubation with the control serum did not 
significantly change the background fluorescence (see 
Table 2). This suggests that the background fluorescence 
is caused by IgG already present in the donor granulo- 
cytes before incubation with serum. 
Interestingly, we have noticed a significant difference 
between patient and control when the granulocyte phag- 
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between the fluorescence intensity of granulocytes incubated with 
healthy donor serum (4% positive cells) and SLE serum (38% positive 
cells). 
ocytosis assay was carried out without fixation. Under 
these conditions serum of a patient with SLE showed a 
median fluorescence intensity, which was about 20% of 
that obtained with the standard procedure. With control 
sera this value was less than 10%. as stated above. 
DISCUSSION 
We have demonstrated that flow cytometric determi- 
nation of CIC with the indirect granulocyte phagocytosis 
test is possible. Sera of SLE patients and controls differ 
significantly with respect to the percentage of granulo- 
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Table 1 
Flow Cvtometric Determination of  CIC for SLE Patients and 
Healthy Ddnors ' 
Control sera SLE sera 
Healthy Positive Positive 
donor cells (%) Clq(%) Patients cells (%) Clq(%) 
1 4 
2 3 
3 4 
4 5 
5 4 
a 
a 
a 
a 
a 
1 14 90 
2 38 87 
3 10 53 
4 14 25 
5 8 16 
aNormal values of Clq  < 7%. 
cytes with a high fluorescence intensity (Figs. 1, 2, and 
Table 1). The high fluorescence of positive cells is mainly 
due to intracellular IgG. This can be concluded from the 
observation that the percentage of positive cells is neg- 
ligible when we omitted the fixation procedure that is 
necessary to introduce FI'I'C-labeled anti-IgG into the 
cell. 
Whether or not the phagocytose determination of CIC 
can be used as a rapid clinical method depends on the 
sensitivity and reproducibility of the test. The sensitiv- 
ity of the test is limited by the background fluorescence 
of cells incubated with control sera. From our results we 
may conclude that the background fluorescence is due 
to intracellular FITC-labeled goat anti-human IgG F(ab') 
2 fragments. These fragments may be bound nonspecifi- 
cally to intracellular components or specifically to intra- 
cellular IgG. In the latter case this IgG was already 
present in the donor granulocytes before phagocytosis, 
since incubation with control serum did not increase the 
background fluorescence (see Table 2). The sensitivity of 
the assay will then be determined by the amount of IgG 
present in the donor granulocytes. If, on the other hand, 
the background is caused by nonspecifically bound anti- 
human IgG, an  increase of the sensitivity can be ex- 
pected if a monoclonal antibody is used instead of the 
polyclonal antibody used in the present study. 
The reproducibility of the test is not limited by the 
sample-to-sample or day-to-day variation, but by the ob- 
served variation when granulocytes of different donors 
are used (Table 2). This problem can be met through the 
use of standard sera for calibration. 
The results in Table 2 indicate that sera with a posi- 
tive score in the Clq-binding assay were also positive 
with the indirect granulocyte phagocytosis assay, al- 
though significant differences in the level of the scores 
are observed. In general, there is a poor correlation 
between the several detection methods for CIC 
(7,8,13,14,16,20,21). 
It is interesting to note that the difference obtained 
for control and patient sera with unfxed granulocytes 
suggests that a procedure without fixation may also be 
used for detection of CIC. In this case membrane-bound 
immune complexes are detected. 
The results shown in Figures 1 and 2 indicate the 
existence of two populations of cells. A minor fraction of 
Table 2 
Flow Cytometric Determination of CIC for One SLE Patient 
and One Healthy Donor Using Four Different Healthy 
Granulocyte Donors 
Granulocytes 
not incubated 
with sera Control sera SLE serum 
Granulocyte positive cells positive cells positive cells 
donor (%I (%I (9%) 
1 3 3 54 
2 2 2 34 
3 2 3 53 
4 N.D." 2 46 
"N.D., not done. 
about 15% shows very little fluorescence, whereas the 
remaining cells have more fluorescence. In view of the 
isolation procedure used, and, since both fractions re- 
vealed the same small-angle light scatter intensity 
(Fig.21, both cell populations must be granulocytes. This 
is in accordance with our microscopic observations that 
10-20% of the granulocytes showed no inclusions, and 
with the recent observations of Bassoe et al. (2), who 
also observed a peak with low fluorescence due to non- 
phagocytes. It should be noted, however, that the rela- 
tive number of nonphagocytes depends on the donor 
granulocytes used. Compared with the microscopic anal- 
ysis, the flow cytometric method is less time-consuming 
and can be more quantitative. However, one should be 
aware of the differences between the two methods. With 
the microscopic method, the total number of inclusions 
are counted, whereas the flow cytometric method deter- 
mines the intensity of the fluorescence per cell, which is 
a measure of the total amount of IC per cell. In order to 
find objective criteria from which the score of the test 
can be determined, a more elaborate study is needed. In 
such a study, standard positive and negataive sera will 
be used in order to eliminate the influence of the use of 
granulocytes of different donors, and reliable quantita- 
tive data would then be obtained. Also, a comparison of 
the flow cytometric method and other methods for detec- 
tion of CIC of patients with different diseases is required. 
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